After UBS: ETFs in the spotlight

Exchange traded funds, the investments that allegedly enabled a junior trader at UBS to chalk up a $2.3bn loss in unauthorised trades, have grown rapidly in recent years. FT columnists Gillian Tett and Martin Wolf plus Ian Gordon of Evolution Securities speak to Daniel Garrahan about how regulators are reacting to a sector that was little noticed before the UBS case.